As filed with the Securities and Exchange Commission on February 8, 2002
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
(Amendment No. 1)
Tender Offer Statement under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934
Inhale Therapeutic Systems, Inc.
(Name of Subject CompanyIssuer and Filing PersonOfferor)
OPTIONS TO PURCHASE COMMON STOCK,
par value $0.0001 per share
(Title of Class of Securities)
457191-10-4
(CUSIP Number of Class of Securities)
Ajit S. Gill
Chief Executive Officer and President
INHALE THERAPEUTIC SYSTEMS, INC.
150 Industrial Road
San Carlos, California 94070
Telephone: (650) 631-3100
(Name, address and telephone number of person authorized to receive
notices and communications on behalf of Filing Person)
Copies
to:
Mark P. Tanoury
Thomas Z. Reicher
John M. Geschke
COOLEY GODWARD LLP
3175 Hanover Street
Palo Alto, California 94304-1130
Telephone: (650) 843-5000
Transaction Valuation* | Amount of Filing Fee** | |
$33,906,010.70 | $3,119.35 |
/ / Check box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
Amount Previously Paid: | Not applicable. | Filing Party: | Not applicable. | ||||
Form or Registration No.: | Not applicable. | Date Filed: | Not applicable. |
/ / Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
Check the appropriate boxes below to designate any transactions to which the statement relates:
/ / | Third-party tender offer subject to Rule 14d-1. | |||
/x/ | Issuer tender offer subject to Rule 13e-4. | |||
/ / | Going-private transaction subject to Rule 13e-3. | |||
/ / | Amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer: / /
CUSIP NO. 457191-10-4
This Amendment No. 1 to Schedule TO amends and supplements the Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission on January 25, 2002, in connection with our offer to exchange certain options granted prior to July 24, 2001 with exercise prices per share greater than or equal to $25.00 per share currently outstanding under the Company's 2000 Non-Officer Equity Incentive Plan, as amended (the "Option Plan"), to purchase shares of the Company's Common Stock, par value $0.0001 per share (the "Common Stock"), held by optionholders as of January 25, 2002 for replacement options to purchase shares of Common Stock to be granted under the Option Plan, upon the terms and subject to the conditions set forth in the Offer to Exchange.
ITEM 12. EXHIBITS.
Exhibit Number |
Description |
|
---|---|---|
99.(a)(1)(A)* | Offer to Exchange, dated January 25, 2002. | |
99.(a)(1)(B)* | Form of Electronic Letter of Transmittal. | |
99.(a)(1)(C)* | Form of Summary of Terms. | |
99.(a)(1)(D)* | Form of Election Form. | |
99.(a)(1)(E)* | Form of Notice of Change in Election from Accept to Reject. | |
99.(a)(1)(F)* | Form of Notice of Change in Election from Reject to Accept. | |
99.(a)(1)(G)* | Powerpoint slide presentation to holders of Eligible Options. | |
99.(a)(1)(H)* | Form of Confirmation of Participation in the Offer to Exchange. | |
99.(a)(1)(I) | Inhale Therapeutic Systems, Inc. Annual Report on Form 10-K, as amended, for its fiscal year ended December 31, 2000, filed with the Securities and Exchange Commission on March 1, 2001 and incorporated herein by reference. | |
99.(a)(1)(J) | Inhale Therapeutic Systems, Inc. Current Report on Form 8-K/A, filed with the Securities and Exchange Commission on August 10, 2001, as amended, and incorporated herein by reference. | |
99.(a)(1)(K) | Inhale Therapeutic Systems, Inc. Current Report on Form 8-K/A, filed with the Securities and Exchange Commission on October 4, 2001 and incorporated herein by reference. | |
99.(a)(1)(L) | Form of Electronic CommunicationNotice to Employees of Amendments to the Offer to Exchange (including Exhibit 1). | |
99.(a)(1)(M) | Form of Electronic CommunicationReminder to Employees of Cancellation Date. | |
99.(b) | Not applicable. | |
99.(d)(1) | Inhale Therapeutic Systems, Inc.'s 2000 Non-Officer Equity Incentive Plan, as amended, (incorporated herein by reference to the indicated exhibit in Inhale's Registration Statement on Form S-8/A (No. 333-71936), filed on January 15, 2002. | |
99.(g) | Not applicable. |
CUSIP NO. 457191-10-4
SCHEDULE TO
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 8, 2002 | ||
INHALE THERAPEUTIC SYSTEMS, INC. | ||
By: |
/s/ Ajit S. Gill |
|
Name: Ajit S. Gill Title: Chief Executive Officer and President |
CUSIP NO. 457191-10-4
INDEX OF EXHIBITS
Exhibit Number |
Description |
|
---|---|---|
99.(a)(1)(A)* | Offer to Exchange, dated January 25, 2002. | |
99.(a)(1)(B)* | Form of Electronic Letter of Transmittal. | |
99.(a)(1)(C)* | Form of Summary of Terms. | |
99.(a)(1)(D)* | Form of Election Form. | |
99.(a)(1)(E)* | Form of Notice of Change in Election from Accept to Reject. | |
99.(a)(1)(F)* | Form of Notice of Change in Election from Reject to Accept. | |
99.(a)(1)(G)* | Powerpoint slide presentation to holders of Eligible Options. | |
99.(a)(1)(H)* | Form of Confirmation of Participation in the Offer to Exchange. | |
99.(a)(1)(I) | Inhale Therapeutic Systems, Inc. Annual Report on Form 10-K, as amended, for its fiscal year ended December 31, 2000, filed with the Securities and Exchange Commission on March 1, 2001 and incorporated herein by reference. | |
99.(a)(1)(J) | Inhale Therapeutic Systems, Inc. Current Report on Form 8-K/A, filed with the Securities and Exchange Commission on August 10, 2001, as amended, and incorporated herein by reference. | |
99.(a)(1)(K) | Inhale Therapeutic Systems, Inc. Current Report on Form 8-K/A, filed with the Securities and Exchange Commission on October 4, 2001 and incorporated herein by reference. | |
99.(a)(1)(L) | Form of Electronic CommunicationNotice to Employees of Amendments to the Offer to Exchange (including Exhibit 1). | |
99.(a)(1)(M) | Form of Electronic CommunicationReminder to Employees of Cancellation Date. | |
99.(b) | Not applicable. | |
99.(d)(1) | Inhale Therapeutic Systems, Inc.'s 2000 Non-Officer Equity Incentive Plan, as amended, (incorporated herein by reference to the indicated exhibit in Inhale's Registration Statement on Form S-8/A (No. 333-71936), filed on January 15, 2002. | |
99.(g) | Not applicable. |
February 8, 2002
To Employees:
NoticeAmendments to the Stock Option Offer to Exchange
Pursuant to Section 14 of the Offer to Exchange dated January 25, 2002 (the "Offer"), we have supplemented and amended the terms of the Offer as indicated in Exhibit 1 attached hereto. Other than as indicated in Exhibit 1, all other terms of the Offer to Exchange remain unchanged.
For additional information about these amendments, or the Offer generally, please do not hesitate to contact Steve Hurst or Bob Harper via email at exchange@inhale.com. You can also reach Steve Hurst by telephone at (650) 631-3118 or Bob Harper at (650) 631-3222.
EXHIBIT 1
AMENDMENTS TO THE OFFER TO EXCHANGE
The Offer to Exchange is hereby supplemented and amended as follows:
"After we accept Eligible Options for exchange and cancellation, we will promptly send each optionholder who accepted the Offer a letter confirming acceptance and the number of Replacement Options that we will grant to the optionholder."
"9. INTERESTS OF DIRECTORS AND OFFICERS; TRANSACTIONS AND ARRANGEMENTS INVOLVING THE OPTIONS.
A list of our directors and executive officers is contained in Schedule A attached to this Offer to Exchange. No director or executive officer of the Company holds Eligible Options under the 2000 Non-Officer Equity Incentive Plan.
There is no agreement, arrangement or understanding between the Company or, to the best of our knowledge, any of our directors or executive officers, and any other person for the purchase or acquisition from the Company of any of its securities, except for the following:
To Employees:
ReminderCancellation Date for Stock Option Offer to Exchange is Approaching
On January 25, 2002, Inhale announced a stock option exchange offer for eligible employees and distributed documents related to the Offer. We are now approaching the deadline for returning your election forms. Whether you accept the Offer or not, you need to make your election, sign the Election Form and ensure delivery of the Election Form to Steve Hurst or Bob Harper at Inhale's corporate offices in San Carlos, California for receipt BEFORE MIDNIGHT PACIFIC STANDARD TIME ON MONDAY, FEBRUARY 25, 2002.
If you have any questions, please do not hesitate to contact Steve Hurst or Bob Harper via email at exchange@inhale.com. You can also reach Steve Hurst by telephone at (650) 631-3118 or Bob Harper at (650) 631-3222.